Skip to content

Menu

LexBlog, Inc. logo
NetworkSub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact
Search
Close

Cannabis Rescheduling Timeframe Ends Speculation of Immediate 280E Tax Relief

By Lance Boldrey, John Fraser, Scott Kocienski & Richard Lieberman on August 28, 2024
Email this postTweet this postLike this postShare this post on LinkedIn

The Drug Enforcement Administration (DEA) announced this week it will hold a hearing regarding the attorney general’s proposal to ease restrictions on marijuana. The hearing is scheduled for the morning of December 2 at the DEA’s headquarters in Arlington, Virginia, effectively delaying any further action on federal cannabis policy until after the upcoming election.

The hearing is intended to gather factual and expert analysis. Anyone interested in participating in the hearing must file a request with the DEA explaining how they are “adversely affected or aggrieved by” some aspect of the proposed rule. They have until September 28 to file a request with the DEA.

This announcement follows the close of the public comment period on the Biden administration’s proposal to reclassify marijuana, during which nearly 43,000 comments were submitted by various stakeholders, including anti-legalization activists, marijuana industry advocates, and state cannabis regulators.

As we’ve reported, the rescheduling process began in October 2022 when President Biden issued an executive order directing Cabinet-level agencies to review federal marijuana prohibition. In August 2023, the Department of Health and Human Services (HHS) conducted a significant review, determining that cannabis has a “currently accepted medical use.” The Department of Justice agreed with the HHS recommendation in May 2024.

In August, federal health regulators recommended rescheduling cannabis after determining that it has a currently accepted medical use in the U.S. and poses less danger than other Schedule I drugs. The U.S. Department of Justice made its formal recommendation to reschedule marijuana in May, following an opinion from the DOJ’s Office of Legal Counsel, which concluded that neither international treaty obligations nor the Controlled Substances Act (CSA) require keeping marijuana in Schedule I.

With Monday’s announcement tax relief for the U.S. cannabis industry is unlikely until next year. If marijuana is reclassified to Schedule 3, cannabis businesses would no longer face restrictions under Section 280E of the Internal Revenue Code although another tax problem could remain. Until then, the IRS expects plant-touching operators to continue paying federal taxes as usual.

Photo of Lance Boldrey Lance Boldrey

R. Lance Boldrey’s practice focuses on tribal and commercial gaming, and on Indian law (with an emphasis on economic development and state-tribal relations). He represents tribes, developers, banks and other non-tribal businesses, as well as state and local governments, and is a frequent…

R. Lance Boldrey’s practice focuses on tribal and commercial gaming, and on Indian law (with an emphasis on economic development and state-tribal relations). He represents tribes, developers, banks and other non-tribal businesses, as well as state and local governments, and is a frequent speaker on Indian law topics. Mr. Boldrey is also a leader of the Firm’s emerging Cannabis Law practice.

Read more about Lance BoldreyEmail
Show more Show less
Photo of John Fraser John Fraser

John provides cannabis businesses with the regulatory guidance and counsel they need to secure and maintain licensure. John has organized, guided, and secured state and local licensure for dozens of cannabis businesses of all sizes and types throughout Michigan.

Read more about John FraserEmail
Photo of Scott Kocienski Scott Kocienski
Read more about Scott KocienskiEmail
Photo of Richard Lieberman Richard Lieberman
Read more about Richard LiebermanEmail
  • Posted in:
    Cannabis
  • Blog:
    Cannabis Law Blog
  • Organization:
    Dykema
  • Article: View Original Source

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS
The Library at LexBlog
  • About LexBlog
  • The Field We Built
  • Library at LexBlog
  • Our Beliefs
  • Our Team
  • Contact LexBlog
  • Disclaimer
  • Editorial Policy
  • Terms of Service
  • Get Started
  • Publishing Solutions
  • Compass
  • Submit a Request
  • Support Center
  • System Status
Copyright © 2026, LexBlog, Inc. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo